A Randomized Controlled Study of Rolapitant for the Prevention of Nausea and Vomiting Following Surgery (Study P04937AM1)(COMPLETED)

NCT00539721 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

619

Enrollment

INDUSTRY

Sponsor class

Conditions

Postoperative Nausea and Vomiting

Interventions

DRUG: Rolapitant Dose 1
DRUG: Rolapitant Dose 2
DRUG: Rolapitant Dose 3
DRUG: Rolapitant Dose 4
DRUG: Ondansetron
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC